首页> 美国卫生研究院文献>BMC Cardiovascular Disorders >Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study
【2h】

Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study

机译:卵磷脂胆固醇酰基转移酶活性和低密度脂蛋白异质性与动脉粥样硬化性心血管疾病风险的关联:一项纵向试验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundLecithin-cholesterol acyltransferase (LCAT) is believed to be involved in reverse cholesterol transport, which is known to play a key role in suppression of atherosclerosis. However, recent investigations have demonstrated that higher LCAT activity, measured in terms of the serum cholesterol esterification rate by an endogenous substrate method, is associated with increased formation of triglyceride (TG)-rich lipoproteins (TRLs), leading to a decrease in the low-density lipoprotein (LDL) particle size. The purpose of this hospital-based longitudinal study was to clarify the causal relationship between changes in the LCAT activity and changes in the LDL-particle size.
机译:背景技术卵磷脂-胆固醇酰基转移酶(LCAT)被认为参与胆固醇的逆向转运,已知其在抑制动脉粥样硬化中起关键作用。但是,最近的研究表明,通过内源底物方法测定的较高的LCAT活性与血清胆固醇酯化率有关,与富含甘油三酸酯(TG)的脂蛋白(TRL)的形成增加相关,从而导致低脂蛋白的降低密度脂蛋白(LDL)粒度。这项基于医院的纵向研究的目的是阐明LCAT活性变化与LDL粒径变化之间的因果关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号